Capillary Leak Syndrome – Another Side Effect Of AstraZeneca CoviShield Vaccine
The European Medicines Agency’s (EMA) safety committee has added another blood condition to the potential side effects of AstraZeneca’s vaccine branded as Covishield in India – the Capillary Leak Syndrome.
AstraZeneca Changes Its COVID-19 Vaccine Name From CoviShield To Vaxzevria Due To Blood Clots Controversy
AstraZeneca has rebranded and changed the name of its COVID-19 vaccine from CoviShield to Vaxzevria. The move is because the company is struggling to convince people that the vaccine is safe amidst the controversy that AstraZeneca COVID-19 vaccine is causing blood clots.